Last updated on January 2020

Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options

Brief description of study

A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options.

Detailed Study Description

This is the first study in patients of F901318. Patients with a limited treatment options will be enrolled and treated with F901318 (olorofim) for up to 12 weeks.

Clinical Study Identifier: NCT03583164

Find a site near you

Start Over

UZ Leuven

Leuven, Belgium
  Connect »

UC Davis Medical Center

Sacramento, CA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »


Pittsburgh, PA United States
  Connect »

Westmead Hospital

Westmead, Australia
  Connect »

The Alfred Hospital

Melbourne, Australia
  Connect »


Nijmegen, Netherlands
  Connect »

UMC Utrecht

Utrecht, Netherlands
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Johns Hopkins Hospital

Baltimore, MD United States
  Connect »

Leningrad Regional Clinical Hospital

Saint Petersburg, Russian Federation
  Connect »